Joseph P. Pellegrino JR - Dec 27, 2021 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Chief Financial Officer, Director
Signature
/s/ Laurie A. Churchill, Attorney-in-fact
Stock symbol
LMAT
Transactions as of
Dec 27, 2021
Transactions value $
-$30,042
Form type
4
Date filed
12/29/2021, 04:57 PM
Previous filing
Dec 27, 2021
Next filing
Mar 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $10.6K +752 +8.5% $14.13* 9.6K Dec 27, 2021 Direct F1
transaction LMAT Common Stock Sale -$39.1K -752 -7.83% $52.00 8.85K Dec 27, 2021 Direct F2
transaction LMAT Common Stock Options Exercise $1.3K +55 +0.62% $23.56 8.9K Dec 27, 2021 Direct F1
transaction LMAT Common Stock Sale -$2.86K -55 -0.62% $52.00 8.85K Dec 27, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -752 -8.75% $0.00 7.84K Dec 27, 2021 Common Stock 752 $14.13 Direct F3
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -55 -0.31% $0.00 17.4K Dec 27, 2021 Common Stock 55 $23.56 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2 This transaction was effected pursuant to a Rule 10b5-1 trading plan established by the Reporting Person.
F3 This option is fully vested and exercisable.
F4 This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.